- Ongoing, recruitingTherapeutic use (Phase IV)
Early ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
This study looks at treating an irregular heartbeat called atrial fibrillation (AF) early in people with a heart condition called hypertrophic cardiomyopathy (HCM). It's trying to find out if early treatment of AF helps prevent serious health issues like stroke or further heart problems.
For: Hypertrophic cardiomyopathy (HCM) is the most common genetically determined disease of the heart · characterized by a varied picture and clinical course. The first comprehensive clinical description of the disease comes from the 1960s. Currently · the disease is diagnosed on the basis of a phenotypic picture showing left ventricular hypertrophyPoland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
The efficacy and safety of Metoprolol as add-on treatment to standard of care in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy aged 8-17 years. A randomized, double-blind, placebo controlled study
This study looks at whether a medicine called Metoprolol can help prevent heart problems in young people with Duchenne Muscular Dystrophy. It compares Metoprolol to a dummy medicine to see if it makes a difference to heart strength.
For: Duchenne muscular dystrophy · Cardiomyopathy · TachycardiaPoland